New drug targets tough pancreatic cancer in early trial
Disease control
Recruiting now
This phase 2 study tests an experimental drug called BT5528 in adults with metastatic pancreatic cancer that has spread and worsened after one prior treatment. The drug targets a specific protein on cancer cells. Researchers will measure how well it shrinks tumors and track side …
Phase: PHASE2 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC